Video
Current developments in PSMA research
Author(s):
“I believe we are getting to an era where we will be able to cure a significant subset of patients who we are not able to cure today,” says Neil H. Bander, MD.
Video Player is loading.
In this video, Neil H. Bander, MD, shares his perspective on what the future of prostate-specific membrane antigen (PSMA) research will look like as well as what current developments are taking place. Bander is the Bernard & Josephine Chaus professor of urologic oncology at Weill Cornell Medicine, New York City, New York.
Related Videos
Ruchika Talwar, MD, on how urologists can get involved in advocacy
Chad Ellimoottil, MD, on how urologists should approach telehealth in changing policy environment
How recombinant BCG could ease strain of supply issues
Katherine Chan, MD, on viral vs non-viral vectors in bladder cancer
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
Pain management disparities in kidney stones point to need for guidelines, experts say
John Taylor, III, MD, on novel options in NMIBC
FDA testosterone labeling changes: How will they affect prescribing?
Why a personalized approach is key to prolapse and OAB management
Timothy Lyon, MD, highlights study assessing accuracy of urology rankings
Related Content
